TW200740781A - Novel compounds - Google Patents

Novel compounds

Info

Publication number: TW200740781A
Authority: TW; Taiwan
Prior art keywords: novel compounds; therapy; processes; formula; preparation
Prior art date: 2005-08-29

Application number

TW095131126A

Other languages

English (en)

Inventor

Roger Bonnert

Alice Flaherty

Garry Pairaudeau

Michael Stocks

Andrew Bailey

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-08-29

Filing date

2006-08-24

Publication date

2007-11-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37809141&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200740781(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-08-24 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2007-11-01 Publication of TW200740781A publication Critical patent/TW200740781A/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Thiazole And Isothizaole Compounds (AREA)

TW095131126A 2005-08-29 2006-08-24 Novel compounds TW200740781A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0501906		2005-08-29

Publications (1)

Publication Number	Publication Date
TW200740781A true TW200740781A (en)	2007-11-01

Family

ID=37809141

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW095131126A TW200740781A (en)	2005-08-29	2006-08-24	Novel compounds

Country Status (8)

Country	Link
US (1)	US20090203753A1 (zh)
EP (1)	EP1957471A1 (zh)
JP (1)	JP2009506110A (zh)
CN (1)	CN101300240A (zh)
AR (1)	AR055617A1 (zh)
TW (1)	TW200740781A (zh)
UY (1)	UY29768A1 (zh)
WO (1)	WO2007027133A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200738658A (en) *	2005-08-09	2007-10-16	Astrazeneca Ab	Novel compounds
TW200738659A (en) *	2005-08-29	2007-10-16	Astrazeneca Ab	Novel compounds
TW200745067A (en)	2006-03-14	2007-12-16	Astrazeneca Ab	Novel compounds
AU2007336074B2 (en) *	2006-12-20	2011-09-22	Astrazeneca Ab	Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases
TW200833670A (en) *	2006-12-20	2008-08-16	Astrazeneca Ab	Novel compounds 569
GB0702458D0 (en)	2007-02-08	2007-03-21	Astrazeneca Ab	Salts 668
CN102124003A (zh)	2008-06-18	2011-07-13	阿斯利康(瑞典)有限公司	作为治疗呼吸系统疾病的β2肾上腺素受体拮抗剂的苯并噁嗪酮衍生物
JP2011524897A (ja) *	2008-06-20	2011-09-08	アストラゼネカ・アクチエボラーグ	β２−アドレナリン受容体活性の調節のための、４−ヒドロキシ−２−オキソ−２，３−ジヒドロ−１，３−ベンゾチアゾール−７−イル化合物を含む医薬組成物
WO2011073662A1 (en) *	2009-12-17	2011-06-23	Astrazeneca Ab	Combination of a benzoxazinone and a further agent for treating respiratory diseases
GB201009801D0 (en)	2010-06-11	2010-07-21	Astrazeneca Ab	Compounds 950
JO3192B1 (ar)	2011-09-06	2018-03-08	Novartis Ag	مركب بنزوثيازولون
CN116655557B (zh) *	2022-02-25	2025-06-20	宁波康柏睿格医药科技有限公司	苯并噻唑类化合物、其制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5648370A (en) *	1990-11-20	1997-07-15	Astra Pharmaceuticals Limited	7-(2-aminoethyl) benzothiazolones
TW356468B (en) *	1995-09-15	1999-04-21	Astra Pharma Prod	Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
GB0217225D0 (en) *	2002-07-25	2002-09-04	Glaxo Group Ltd	Medicinal compounds
AR040962A1 (es) *	2002-08-09	2005-04-27	Novartis Ag	Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
GB0402797D0 (en) *	2004-02-09	2004-03-10	Novartis Ag	Organic compounds

2006
- 2006-08-24 TW TW095131126A patent/TW200740781A/zh unknown
- 2006-08-28 EP EP06769630A patent/EP1957471A1/en not_active Withdrawn
- 2006-08-28 US US12/065,165 patent/US20090203753A1/en not_active Abandoned
- 2006-08-28 CN CNA200680040705XA patent/CN101300240A/zh active Pending
- 2006-08-28 JP JP2008528983A patent/JP2009506110A/ja active Pending
- 2006-08-28 UY UY29768A patent/UY29768A1/es unknown
- 2006-08-28 WO PCT/SE2006/000980 patent/WO2007027133A1/en not_active Ceased
- 2006-08-29 AR ARP060103748A patent/AR055617A1/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20090203753A1 (en)	2009-08-13
JP2009506110A (ja)	2009-02-12
AR055617A1 (es)	2007-08-29
WO2007027133A1 (en)	2007-03-08
EP1957471A1 (en)	2008-08-20
UY29768A1 (es)	2007-03-30
CN101300240A (zh)	2008-11-05

Publication	Publication Date	Title
TW200801003A (en)	2008-01-01	Novel compounds
TW200833670A (en)	2008-08-16	Novel compounds 569
SE0202133D0 (sv)	2002-07-08	Novel compounds
TW200800999A (en)	2008-01-01	Novel compounds
SE0104140D0 (sv)	2001-12-07	Novel Compounds
SE0302811D0 (sv)	2003-10-23	Novel compounds
MXPA02012425A (es)	2003-04-25	Compuestos nuevos.
TW200745114A (en)	2007-12-16	Novel compounds
TW200508214A (en)	2005-03-01	Novel compounds
DE602004021472D1 (en)	2009-07-23	Pyrimiidinverbindungen
TW200738658A (en)	2007-10-16	Novel compounds
SE0200920D0 (sv)	2002-03-25	Novel compounds
SE0401762D0 (sv)	2004-07-05	Novel compounds
TW200745084A (en)	2007-12-16	Novel compounds
SE0202539D0 (sv)	2002-08-27	Compounds
MX2010009022A (es)	2010-09-07	Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
SE0300480D0 (sv)	2003-02-21	Novel compounds
SE0302139D0 (sv)	2003-07-28	Novel compounds
DE602004024213D1 (en)	2009-12-31	Aminopropanolderivate
SE0303541D0 (sv)	2003-12-22	New compounds
TW200738659A (en)	2007-10-16	Novel compounds
MX2009006010A (es)	2009-06-16	Derivados de amina y su uso en enfermedades mediadas por el adrenoreceptor beta 2.
TW200639156A (en)	2006-11-16	New compounds
TW200716529A (en)	2007-05-01	New compounds II
TW200740781A (en)	2007-11-01	Novel compounds